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Coronary Heart Disease Risk Factors andMortality
To the Editor: Dr Canto and colleagues1 found that hospi-
tal mortality increased as the number of cardiovascular risk
factors declined. This inverse relationship is perplexing and
the potential explanations discussed by the authors appear
not completely satisfactory.
The authors just considered the number of risk factors,
whereas the severity of each factor was not evaluated. Blood
pressure, plasma glucose, and lipids are continuous, not dis-
creet, variables that exert a dose-dependent effect on car-
diovascular risk.2 It would be of interest to see the results
of the analysis conducted considering these parameters,
which also would help to clarify the still controversial as-
sociation of themetabolic syndrome andmortality aftermyo-
cardial infarction (MI).3
It also would be interesting to know if the inverse corre-
lation is still present after correction for one of themost im-
portant predictors of mortality after acute coronary syn-
drome,4 the baseline infarct size.
Last, traditional cardiovascular risk factors do not fully
explain the pathophysiological process of atherothrombo-
sis in acute ischemic heart disease. Several studies have iden-
tified a series of emerging biomarkers reflecting thrombo-
sis, inflammation, and oxidative stress.5 Do the authors have
any data about this issue?
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To the Editor: The study by Dr Canto and colleagues1
provides an example of an epidemiological phenomenon
that deserves wider recognition. Differential selection
from an underlying population cohort into a study data
set can reverse the direction of observed associations,
making a deleterious factor appear protective. It is well-
known that conditioning on a variable that is affected by
both an exposure and outcome can produce a distortion
known as selection bias.2 Admission into the analysis
data set in this study was a function of both the exposure
(number of cardiovascular risk factors) and the outcome
(all-cause, in-hospital, or 30-day mortality) because
deaths occurring before hospitalization and patients with
existing cardiovascular disease diagnoses were excluded.
Approximately 30% of MIs lead to death prior to hospi-
talization.3 In the study, 75% of those who were admitted
to the hospital after their MI were excluded (1.62 million
of 2.16 million; Figure 1 in the article).
The combined effect of these 2 selection mechanisms
means that individuals with more cardiovascular risk fac-
tors were more likely to be excluded. If an increased num-
ber of risk factors accelerate mortality so that more events
occur in the prehospital window rather than during hospi-
talization or 30-day follow-up, risk factors will appear to be
protective.4 The study results are therefore understandable
in terms of selection bias and require no elaborate specu-
lation about pathophysiological processes1 or “novel but as-
yet uncharacterized and deadly CVD [cardiovascular dis-
ease] risk factors.”5
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In Reply: Our study challenges conventional wisdom that
patients with more coronary heart disease (CHD) risk fac-
tors haveworse outcomes following their firstMI.We found
that patients withmultiple CHD risk factors presentedmuch
earlier in life withMI and had lower hospital mortality than
patients with fewer or no risk factors. We confirmed that
the high prevalence of risk factor exposure in patients with
MI was consistent with the prior literature.
Dr Santulli seeks additional information that may en-
hance our study, such as the influence of a dose-dependent
effect of CHD risk factors, presence of the metabolic syn-
drome, other novel risk markers, and infarct size. Unfortu-
nately, these factors were not available in the National Reg-
istry ofMyocardial Infarction. Although baseline infarct size
was not recorded, the finding of an inverse relationship be-
tween the number of CHD risk factors and mortality was
consistently observed among patients with low-, interme-
diate-, and high-risk features using 2 well-validated mea-
sures of infarct severity (Killip classification and TIMI Risk
Index).
Ms Banack and colleagues suggest that bias in the selec-
tion of our study cohort could have reversed the direction
of observed associations, making a deleterious factor ap-
pear protective. An MI cohort with no previous cardiovas-
cular disease represents amore uniform population to study
given the differences inmanagement and treatment after ath-
erosclerosis is manifest. Excluding patients with previous
cardiovascular disease simply presents findings generaliz-
able only to patients without previous disease. When our
analysis was rerun using only an MI cohort with previous
cardiovascular disease (N=630 210), our results did not
change appreciably (TABLE).
Banack et al also raise the possibility that patients with
multiple CHD risk factors might have died disproportion-
ately before hospitalization. This is merely speculative.
No prior study has examined the relationship between
the number of CHD risk factors and mortality among
patients with suspected MI who died prior to hospital
arrival, perhaps due to the challenges of confirming MI in
the prehospital setting.
In the discussion of our findings, we devoted 4 para-
graphs to methodological issues that may have limited gen-
eralizability and inferences of causality, including risk fac-
tor misclassification, bias with case ascertainment, residual
confounding, healthy survivor bias, and index event bias.1
Index event bias (also known as reverse epidemiology or
collider stratification bias) may affect research that exam-
ines disease progression and severity when there are mul-
tiple risk factors for progression or for severity that are also
risk factors for having the disease in the first place.1We also
present biologically plausible alternative interpretations of
our findings, including receipt of more aggressive treat-
ments and follow-up care among patientswithmultipleCHD
risk factors.
In summary, we report an unexpected and possibly con-
troversial association that, like all observational findings,
should be considered hypothesis-generating and further ex-
plored in terms of health care provided to patients who reach
the hospital alive with first MI.
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Urinary SodiumExcretion andCardiovascular Events
To the Editor: Dr O’Donnell and colleagues, in their study
on urinary sodium excretion and risk of cardiovascular
events,1 reached the counterintuitive conclusion that so-
dium restriction increased the risk of cardiovascular events,
which runs counter to the consistent evidence that, in in-
dividuals with hypertension, decreased sodium intake re-
duces blood pressure and improves the effectiveness of treat-
ment with antihypertensive agents.2-4
Table. Crude Hospital Mortality of Patients With Myocardial Infarction (MI) and Previous Cardiovascular Diseasea
No. of Risk Factors at Presentationb
0 1 2 3 4 5
No. (%)
MI (N = 630 210) 83 978 (13.3) 195 238 (31.0) 205 224 (32.6) 111 384 (17.7) 30 893 (4.9) 3493 (0.6)
Crude hospital mortality 15 790 (18.8) 30 825 (15.8) 25 894 (12.6) 10 336 (9.3) 2293 (7.4) 220 (6.3)
aData are from the National Registry of Myocardial Infarction, 1994-2006. Excluded patients without prior cardiovascular disease, those who had been transferred, and those with
missing data.
bFive major risk factors: smoking, diabetes, dyslipidemia, hypertension, and family history of coronary heart disease.
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